PGEN Precigen, Inc.
PGEN Precigen, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $4.15 · VWAP $5.10 · +21.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster COO, Director + 1 other sold $2.3M, Aug 25–28
Coverage
1 watchlist
PGEN Price Structure
Loading timeframes…
Peers
Every watchlist PGEN belongs to, members best 30-day change first — PGEN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How PGEN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about PGEN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 4 days ago · Oct 19
- Precigen (PGEN) Q2 2026 Earnings Results & Call Transcript
- Precigen (PGEN) Q4 2025 Earnings Results & Call Transcript
- Precigen, Inc. News and Press Releases | PR Newswire
- Precigen Reports Full Year 2024 Financial Results and Business Updates
- Precigen Reports Full Year 2025 Financial Results and Business Updates
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
PGEN research tape
7 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.